Sorafenib
Treatment used for 4 conditions
Total Trials
53
Total Participants
16K
Avg Effectiveness
64%
Avg Safety Score
40%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.
Liver cancer due to NASH
Effectiveness:70%
Safety:45%
Trials:10
Participants:5K
Liver cancer due to alcohol use
Effectiveness:55%
Safety:55%
Trials:8
Participants:5K
Thyroid cancer
Effectiveness:60%
Safety:30%
Trials:20
Participants:4K
Liver cancer due to hepatitis B
Effectiveness:70%
Safety:30%
Trials:15
Participants:3K